Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8623745 | 8503268 | F | 8623745-6 | 20120304 | 20120820 | 20120827 | EXP | JP-PFIZER INC-2012088261 | PFIZERINC | 38 | YR | F | Y | 72 | KG | 20120827 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
8623745 | 1020671044 | PS | ZOSYN | 1 | INTRAVENOUS DRIP | UNK | 050684 | ||||
8623745 | 1020671047 | C | METFORMIN HCL | 1 | ORAL | 250 MG, 1X/DAY | |||||
8623745 | 1020671048 | C | MUCODYNE | 2 | ORAL | 1500 MG, 1X/DAY | |||||
8623745 | 1020671045 | C | HUMALOG | 1 | SUBCUTANEOUS | 27 IU, 1X/DAY | |||||
8623745 | 1020671046 | C | LANTUS | 1 | SUBCUTANEOUS | 16 IU, 1X/DAY | |||||
8623745 | 1020671049 | C | ASTOMIN | 2 | ORAL | 30 MG, 1X/DAY |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
8623745 | 1020671044 | PYELONEPHRITIS |
8623745 | 1020671047 | DIABETES MELLITUS |
8623745 | 1020671048 | PRODUCTIVE COUGH |
8623745 | 1020671045 | DIABETES MELLITUS |
8623745 | 1020671046 | DIABETES MELLITUS |
8623745 | 1020671049 | ANTITUSSIVE THERAPY |
Outcome of event
Event ID | OUTC COD |
---|---|
8623745 | HO |
Reactions reported
Event ID | PT |
---|---|
8623745 | INTERSTITIAL LUNG DISEASE |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
8623745 | 1020671044 | 20120228 | 20120304 | 6 | DAY |
8623745 | 1020671048 | 20120228 | 20120314 | 16 | DAY |
8623745 | 1020671049 | 20120228 | 20120314 | 16 | DAY |